All news

IDEXX Labs beats estimates, raises guidance as stock gains

Alpha Vantage · Yahoo Finance · · AI-summarised by FinFlash

IDEXX Laboratories Inc. reported strong third-quarter results, exceeding analyst expectations for both earnings per share and revenue. The company also raised its full-year 2026 revenue and EPS guidance, leading to a 2.57% gain in pre-market trading. Key drivers included robust CAG Diagnostics recurring revenue growth and significant placements of IDEXX inVue Dx analyzers.

Read original source

IDXX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.